Ekadharma International releases transcript of incidental public expose on Zoom

• Ekadharma International held an incidental public expose on Sept. 8, 2026; attended by the President Director and a Director.
• Management confirmed Fujian Youyi’s planned 51% acquisition will trigger a mandatory tender offer under OJK rules.
• Tender offer price remains unfixed; to be negotiated using an independent valuation, aligned with market fairness principles.
• Fujian Youyi’s control rationale centers on building an overseas production base in Southeast Asia to expand international market presence.
• Transaction process remains ongoing; completion targeted in Q4 2026; dividend policy expected to continue during the transition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Ekadharma International Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32146749) on September 09, 2026, and is solely responsible for the information contained therein.